López-Herceetal.CriticalCare2014,18:607
http://ccforum.com/content/18/6/607
RESEARCH Open Access
Post return of spontaneous circulation factors
associated with mortality in pediatric in-hospital
cardiac arrest: a prospective multicenter
multinational observational study
Jesús López-Herce1,2*, Jimena del Castillo1,2, Martha Matamoros3, Sonia Canadas4, Ana Rodriguez-Calvo5,
Corrado Cecchetti6, Antonio Rodríguez-Núnez7, Ángel Carrillo1,2 and Iberoamerican Pediatric Cardiac Arrest Study
Network RIBEPCI8
Abstract
Introduction: Moststudieshaveanalyzedpre-arrestandresuscitationfactorsassociatedwithmortalityaftercardiacarrest
(CA)inchildren,butmanypatientsthatreachreturnofspontaneouscirculationdiewithinthenextdaysorweeks.The
objectiveofourstudywastoanalyzepost-returnofspontaneouscirculationfactorsassociatedwithin-hospitalmortality
aftercardiacarrestinchildren.
Methods:Aprospectivemulticenter,multinational,observationalstudyin48hospitalsfrom12countrieswasperformed.
Atotalof502childrenagedbetween1monthand18yearswithin-hospitalcardiacarrestwereanalyzed.Theprimary
endpointwassurvivaltohospitaldischarge.Univariateandmultivariatelogisticregressionanalyseswereperformedto
assesstheinfluenceofeachpost-returnofspontaneouscirculationfactoronmortality.
Results:Returnofspontaneouscirculationwasachievedin69.5%ofpatients;39.2%survivedtohospitaldischargeand
88.9%ofsurvivorshadgoodneurologicaloutcome.Intheunivariateanalysis,post-returnofspontaneouscirculationfac-
torsrelatedwithmortalitywerepH,basedeficit,lacticacid,bicarbonate,FiO2,needforinotropicsupport,inotropicindex,
doseofdopamineanddobutamineat1hourandat24hoursafterreturnofspontaneouscirculationaswellasPediatric
IntensiveCareUnitandtotalhospitallengthofstay.Inthemultivariateanalysisfactorsassociatedwithmortalityat1hour
afterreturnofspontaneouscirculationwerePaCO <30mmHgand>50mmHg,inotropicindex>14andlacticacid
2
>5mmol/L.Factorsassociatedwithmortalityat24hoursafterreturnofspontaneouscirculationwerePaCO >50mmHg,
2
inotropicindex>14andFiO ≥0.80.
2
Conclusions:Secondaryin-hospitalmortalityamongtheinitialsurvivorsofCAishigh.Hypoventilation,
hyperventilation,FiO ≥0.80,theneedforhighdosesofinotropicsupport,andhighlevelsoflacticacidwere
2
themostimportantpost-returnofspontaneouscirculationfactorsassociatedwithin-hospitalmortalityin
childreninourpopulation.
*Correspondence:pielvi@hotmail.com
1PediatricIntensiveCareDepartment,HospitalGeneralUniversitarioGregorio
Maranón,DrCastelo47,28009Madrid,Spain
2InstitutodeInvestigaciónSanitariadelHospitalGregorioMarañónde
Madrid,ReddeSaludMaternoInfantilydelDesarrollo(RedSAMID),Dr
Castelo47,28009Madrid,Spain
Fulllistofauthorinformationisavailableattheendofthearticle
©2014López-Herceetal.;licenseeBioMedCentralLtd.ThisisanOpenAccessarticledistributedunderthetermsofthe
CreativeCommonsAttributionLicense(http://creativecommons.org/licenses/by/4.0),whichpermitsunrestricteduse,
distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycredited.TheCreativeCommonsPublic
DomainDedicationwaiver(http://creativecommons.org/publicdomain/zero/1.0/)appliestothedatamadeavailableinthis
article,unlessotherwisestated.
López-Herceetal.CriticalCare2014,18:607 Page2of14
http://ccforum.com/content/18/6/607
Introduction Patient-related variables and arrest and life support-
Moststudieshaveanalyzedpre-arrestandresuscitationfac- relatedparametershavebeenpreviouslypublished[11]and
tors associated with mortality after cardiac arrest (CA) in also the relationship between ventilation and oxygenation
children[1-13].Previousstudieshaveshownthatlowerhu- withmortality[14].Inthepresentstudyweanalyzedthein-
man development index of countries, characteristics of the fluence on survival of several post-ROSC parameters, such
hospital, CA that occurred out of hospital and out of the as arterial gasometry and lactic acid at the first hour and
PediatricIntensiveCareUnit(PICU),oncohematologicdis- 24 hours after ROSC, the need for mechanical ventilation,
ease,treatmentwithinotropicdrugsatthetimeoftheCA, recovery of spontaneous breathing (although mechanical
CA due to neurological disease or sepsis, time to the initi- ventilationcould beneeded), theneed for vasoactivedrugs
ation of resuscitation, asystole as the initial electrocardio- and doses of vasoactive drugs, vasoactive-inotropic index
graphic (ECG) rhythm, need for adrenaline, bicarbonate or (VIS) [18], and ECG rhythm after ROSC. Hospital course
fluidexpansionandthedurationofcardiopulmonaryresus- and clinical and neurological status at hospital discharge
citation(CPR)areassociatedwithhighermortality[1-13]. according to the pediatric cerebral performance category
An important percentage of patients that reach return [PCPC] were registered [19]. Variable definitions were
of spontaneous circulation (ROSC) die within the next basedonUtstein-styleguidelines[16,17].Theprimaryend-
days or weeks. However, there are no multicenter, multi- pointwassurvivaltohospitaldischarge.Thesecondaryout-
national prospective studies on CA in children to have come measure was neurological status at hospital
analyzed post-ROSC prognostic factors. In previous discharge; a good neurological status was defined as a
studies performed on the same prospective register we PCPCscoreof1or2[19].
have analyzed the pre-arrest and resuscitation factors Statistical analyses were conducted using SPSS software
[11] and the ventilation and oxygenation factors associ- version18.1(SPSSInc,Chicago,IL,USA).Outcomeswere
ated with mortality [14]. The objective of the present comparedbetweengroupsusing the chi-square(χ2) testor
study was to analyze the factors affecting mortality and Fisher’s exact test for categorical variables. Univariate and
neurological outcome of in-hospital CA in children. The multivariate logistic regression analysis was performed to
hypothesis was that respiratory status and hemodynamic assesstheinfluenceofeachoneofthefactorsonmortality.
status are the most important prognosis factors after Alogisticregressionmodelwasconstructedforvariablesat
ROSCinchildren. 1 hour and at 24 hours after ROSC. All individual factors
with statistical significance in the univariate analysis and
Methods P <0.1 were eligible for inclusion in the logistic regression
An open multicenter prospective study was designed model. Receiver operator characteristic (ROC) curves were
and information and an invitation to participate were usedtodecidedcutoffsvaluesforVISandlacticacid.Ven-
sent tothepediatric departmentsandPICUsof hospitals tilation and oxygenationcutoff valueswere chosenaccord-
in Latin-American countries, Spain, Portugal, and Italy. ing to previous studies [20,21] and normal limits of pH,
The study was approved by local Institutional Review ventilation and oxygenation. Finally a logistic regression
Boards (Additional file 1). Registration on the website model was constructed including patient-related variables,
[15] was necessary to participate in the study. Consent arrest-andlifesupport-relatedparameters,andpost-ROSC
of parents of patients was not considered necessary be- parameters.Adjustedoddsratios(OR)and95%confidence
cause it was an observational study during and after CA intervals (CI) were calculated for each model. ROC curves
anditisnecessary toobtain data immediately. wereusedtoassessthepredictivecapacityofeachmodel.
A protocol was drawn up in accordance with the
Utstein style [16,17]. Children aged from 1 month Results
to 18 years who suffered in-hospital CA between Forty-eight hospitals from twelve countries participated
December 2007 and December 2009 were included. CA in the study. The analysis included 563 episodes of in-
was defined by the presence of all the following signs: hospital CA in 502 patients. CA occurred in the PICU
unresponsiveness,apnea,absenceofsignsoflifeandab- in 50% of cases, in the emergency department in 26.8%,
sence of a palpable central pulse or bradycardia with andinotherhospitalareasin23.2%.
lessthan60beatsperminute(bpm)withpoorperfusion Return of spontaneous circulation (ROSC) for more
in infants requiring external cardiac compressions and than 20 minutes was achieved in 349 patients (69.5%),
assistedventilation. but 152 (30.3%) patients died later in hospital due to
All data were entered via a secure, encrypted website new CA (32.9%), multiple organ dysfunction (27%),
and were electronically submitted to the coordinating limitation of medical therapy (25%) or brain death
center. That center performed a review of all records to (15.1%): 197 patients (39.2%) survived to hospital dis-
ensure data quality, and site investigators were queried charge. Five patients were rescued with extracorporeal
tocompletemissingdata andresolvediscrepancies. membrane oxygenation (ECMO) during CPR and four
López-Herceetal.CriticalCare2014,18:607 Page3of14
http://ccforum.com/content/18/6/607
of them survived to hospital discharge. The characteris- 42.1% higher mortality than those who did not need it
tics of the 502 patients, pre-arrest factors, and cardiac 26.9%(P=0.036).Finally,thelengthofPICUstayandtotal
arrestandresuscitationfactorsassociatedwithmortality hospitalstaywasshorterinnon-survivors.
havebeenpreviouslypublished[11]. Table 2 summarizes post-ROSC factors and their rela-
tionshipwithsurvivaltohospitaldischargeintheunivari-
Post-ROSCfactorsassociatedwithmortality ateregressionanalysis.Theneedforinotropicsupport,an
Table 1 shows the comparison between survivors and inotropic index greater than 14, the absence of spontan-
non-survivors in post-ROSC factors. Non-survivors had eousbreathing,PaCO <30mmHgor>50mmHg,FiO ≥
2 2
lower pH, higherbaseexcess, higherlacticacidlevels and 0.80 and lactic acid levels >5 mmol/L at 1 hour after
higher inspired oxygen fraction (FiO ) at 1 and 24 hours ROSC, as well as pH <7.30, PaCO >50 mmHg and
2 2
after ROSC than survivors. A greater percentage of non- FiO >50% at 24 hours after ROSC were significantly
2
survivors needed inotropic support, and they required associated with higher mortality rates. There were no
higher doses of dopamine and dobutamine, and had a significant differences in post-ROSC PaO between sur-
2
higher inotropic score than survivors did. Nevertheless, vivors and non-survivors patients, even when the 24
the percentage of patients receiving milrinone was lower patients with cyanotic heart disease and 6 patients on
innon-survivorsthaninsurvivors.Whenpatientswithout ECMO were excluded of analysis.
inotropic support before CA were analyzed separately, In the multivariate analysis, factors associated with
children who required inotropic support after ROSC had mortalityat1hourafterROSCwerePaCO <30mmHg
2
Table1Comparisonbetweensurvivorsandnon-survivors
Numberof Non-survivors Survivors P-value
patients
Median(IQR) Median(IQR)
Gasometryat1h
pH 259 7.23(7.03to7.35) 7.29(7.17to7.38) 0.004
PaO,mmHg 253 78.5(45.0to125.0) 81.0(47.0to136.0) 0.476
2
PaO/FiO 231 85.5(50.75to189.5) 111(63to242) 0.101
2 2
PaCO,mmHg 255 46(32to63) 42(34to52) 0.314
2
HCO mEq/L 241 18(12.0to24.5) 21(15to25) 0.064
3
BE 233 -8(-2to-15) -6(-0.75to-12) 0.049
Lacticacid,mmol/L 136 7.2(7to13) 4.1(1.89to8) 0.002
FiO 249 100(72.5to100) 100(50to100) 0.034
2
Gasometryat24h
pH 209 7.35(7.26to7.42) 7.40(7.34to7.45) 0.001
PaO,mmHg 205 77(50to124) 82(49.75to119.25) 0.924
2
PaO/FiO 178 125(70.25to242.08) 111(63to242) 0.031
2 2
PaCO,mmHg 208 42.5(34.25to53.5) 41(35to46) 0.175
2
HCO,mEq/L 205 22(19to27) 25(21to29) 0.009
3
BE 186 -2(-5to3.1) 1(-3to5) 0.031
Lacticacid,mmol/L 123 2(1.2to6.47) 1.4(0.9to2.25) 0.007
FiO 191 80(50to100) 45(30to65) 0.001
2
Lacticacidclearance,% 99 60(25to75) 68.63(27.81to84.70) 0.385
MechanicalventilationafterROSC,% 215 94.4 93.5 0.756
Vasoactivetreatment
PatientswithvasopressorsafterROSC,% 173 76.3 63.9 0.039
InotropicscoreafterROSC 154 80.7(121.6) 38.3(78.7) 0.001
Lengthofstay
DaysinthePICU 224 7.9(14.7) 17.4(19.4) 0.001
Daysinhospitalward 118 4.5(6.9) 17.3(19.4) 0.001
Significantvaluesmarkedinbold.BE,baseexcess;PICU,PediatricICU;ROSC,returnofspontaneouscirculation;FiO inspiredoxygenfraction;PaO arterialpartial
2, 2,
pressureofoxygen.
López-Herceetal.CriticalCare2014,18:607 Page4of14
http://ccforum.com/content/18/6/607
Table2Univariateanalysisofmortalityaccordingtopost-returnofspontaneouscirculationfactors
Patients,number Patients,% Mortality,% Oddsratio 95%CI P-value
Mechanicalventilation
No 42 6.1 41.2 1
Yes 173 93.9 45 3.273 0.713to15.027 0.127
Vasoactivedrugs
No 79 31.3 29.1 1
Yes 173 68.7 42.8 1.820 1.028to3.222 0.040
Vasoactive-inotropicscore
<14 62 40.3 29 0.390
>14 92 59.7 51 2.564 1.288to5.050 0.007
ElectrocardiographicrhythmafterROSC
Sinusrhythm 230 72.8 43.5 1
Otherrhythms 86 27.2 53.5 1.495 0.909to2.459 0.113
Recoveryofspontaneousbreathing
Yes 86 26 22.1 1
No 245 74 57.1 4.694 2.659to8.333 0.001
pH1h
7.30to7.50 96 37.1 37.5 1
<7.30 154 59.5 48.7 1.582 0.941to2.662 0.084
>7.50 9 3.5 22.2 0.476 0.094to2.418 0.371
PaO 1h
2
60to200mmHg 123 48.6 44.7 1
<60mmHg 96 37.9 43.8 0.962 0.562to1.646 0.887
>200mmHg 34 13.4 32.4 0.591 0.265to1.318 0.199
PaCO 1h
2
30to50mmHg 133 52.2 33.1 1
<30mmHg 37 14.5 62.2 3.323 1.560to7.079 0.002
>50mmHg 85 33.3 52.9 2.276 1.302to3.978 0.004
CO H1h
3
20to26mEq/L 75 31.1 36 1
<20mEq/L 118 49 46.6 1.552 0.857to2.812 0.147
>26mEq/L 48 19.9 41.7 1.27 0.604to2.669 0.528
Baseexcess1h
+4to-4 48 20.6 37.5 1
<-4 154 66.1 46.8 1.463 0.753to2.844 0.261
>+4 31 13.3 41.9 1.204 0.479to3.027 0.694
FiO 1h
2
<0.50 42 16.7 12.1 1
0.50to0.79 41 16.3 12.9 1.150 0.468to2.847 0.756
≥0.80 169 67.1 75 2.120 1.044to4.311 0.038
PaO /FiO 1h
2 2
>300 166 16.7 45.5 1
200to300 37 11.7 25.8 0.417 0.154to1.134 0.087
<200 28 71.6 46 1.024 0.530to1.978 0.945
López-Herceetal.CriticalCare2014,18:607 Page5of14
http://ccforum.com/content/18/6/607
Table2Univariateanalysisofmortalityaccordingtopost-returnofspontaneouscirculationfactors(Continued)
Lacticacid1h
<2mmol/L 27 19.9 22.2 1
2to5mmol/L 39 28.7 28.2 1.375 0.438to4.318 0.585
>5mmol/L 70 51.5 51.4 3.706 1.335to10.29 0.012
pH24h
7.30to7.50 158 75.6 27.8 1
<7.30 39 18.7 53.8 3.023 1.472to6.205 0.003
>7.50 70 5.7 33.3 1.295 0.371to4.520 0.685
PaO 24h
2
60to200mmHg 121 59 32.2 1
<60mmHg 70 34.1 28.6 0.841 0.442to1.601 0.598
>200mmHg 14 6.8 57.1 2.803 0.910to8.636 0.073
PaCO 24h
2
30to50mmHg 123 68.3 25.2 1
<30mmHg 14 7.8 35.7 1.649 0.513to5.294 0.401
>50mmHg 43 23.9 51.2 3.109 1.508to6.409 0.002
CO H24h
3
20to26mEq/L 90 43.9 36.7 1
<20mEq/L 41 20 43.9 1.352 0.638to2,865 0.432
>26mEq/L 74 36.1 24.3 0.555 0.281to1,099 0.091
Baseexcess24h
+4to-4 90 48.4 30 1
<-4 52 28 40.4 1.581 0.774to3.229 0.209
>+4 44 23.7 22.7 0.686 0.297to1.585 0.378
FiO 24h
2
<0.50 80 41.9 22.1
0.50to0.79 48 25.1 25 2.376 1.051to5.371 0.038
≥0.80 63 33 52.9 5.778 2.726to12.245 0.001
PaO /FiO 24h
2 2
>300 116 18.2 21.6 1
200to300 34 16.3 30.3 2.327 0.988to5.481 0.053
<00 28 65.5 39.1 1.576 0.536to4.636 0.408
Lacticacid24h
<2mmol/L 73 59.3 23.3 1
2to5mmol/L 29 23.6 37.9 2.013 0.798to5.081 0.139
>5mmol/L 21 17.1 47.6 2.995 1.086to8.254 0.034
Lacticacidclearance
>50% 56 55.9 28.8 1
≤50% 43 44.1 30.8 1.099 0.497to2.433 0.841
Significantvaluesmarkedinbold.Lactidacidclearance:(lactateafterROSCminuslactate24hoursafterROSC)×100/lactateafterROSC.ROSC,returnof
spontaneousofcirculation;FiO inspiredoxygenfraction;PaO arterialpartialpressureofoxygen.
2, 2,
and >50 mmHg, inotropic index >14 and lactic acid The logistic regression model at 1 hour after ROSC
>5 mmol/L (Table 3). Factors associated with mortality had an AUC of 0.733 (CI 0.681 to 0.785; P =0.001). The
at 24 hours after ROSC were PaCO >50 mmHg, ino- logisticregressionmodelat24hoursafterROSChadan
2
tropicindex>14andFiO2≥0.8(Table3). AUCof0.769(CI0.720to0.819;P=0.001),(Figure1).
Table3Multivariatelogisticregressionstudyincludingmortalityriskfactorsat1hourand24hoursafterreturnof
spontaneouscirculation
Oddsratio 95%CI P-value
1hourafterreturnofspontaneouscirculation
PaCO <30mmHg 2.640 1.190to5.857 0.017
2
PaCO >50mmHg 1.950 1.063to3.576 0.031
2
Lacticacid>5mmol/L 2.021 0.926to4.413 0.077
Vasoactive-inotropicscore>14 2.454 1.252to4.810 0.009
24hoursafterROSC
PaCO >50mmHg 2.541 1.156to5.587 0.020
2
FiO ≥0.80 3.864 1.698to8.794 0.001
2
Vasoactive-inotropicscore>14 2.070 1.008to4.249 0.047
Post-ROSCfactorsassociatedwithneurologicaloutcome Theunivariateanalysisshowedthatdobutamineadmin-
Neurological status at hospital discharge was assessed in istration and lactic acid levels >5 mmol/L at 1 hour, and
120 patients (60.9%), and 107 of them (89%) had a nor- pH >7.50, PaCO >50 mmHg and BE >4 mEq/L at
2
mal neurological status or showed mild disability (PCPC 24 hours after ROSC were associated with poor neuro-
l or 2). PCPC before CA and at hospital discharge was logical evolution (Table 5).
compared. Only 2.8% of patients with PCPC 1 or 2 be- Inthemultivariateanalysistheonlyfactorassociatedwith
foreCApresentedaPCPC>2 athospitaldischarge. poorneurologicaloutcomeat1hourafterROSCwaslactic
When comparing patients with good and bad neuro- acid above 5 mmol/L (OR 9.902, CI (1.992 to 51.008);
logical outcome (PCPC >2), at 1 hour after ROSC those P =0.006). None of the factors at 24 hours after ROSC
with a bad outcome had significantly lower levels of bicar- showedstatisticalsignificanceinthemultivariateanalysis.
bonate (19.1 (7.4) mEq/L versus 21.8 (6.9) mEq/L;
P=0.025),higherlacticacidlevels(8.1(6.5)mmol/Lversus Pre-arrest,resuscitationandpost-ROSCfactors
5.8 (11.3) mmol/L; P =0.003) and higher base excess (BE) Themultivariate analysis includingpre-arrest factors,re-
(-7.1 (9.4) mEq/L versus -3.4 (9.6) mEq/L; P =0.042) suscitation factors and post-ROSC factors is shown in
(Table 4). A higher percentage of patients with bad neuro- Table 6. Factors associated with in-hospital mortality
logical outcome received dobutamine (40.9%) than those were hemato-oncologic illness, neurologic cause of ar-
withgoodneurologicaloutcome(19%)P=0.007(Table4). rest, CA in the emergency department, treatment with
ytivitisneS
00.1
57.0
05.0
52.0
00.0
López-Herceetal.CriticalCare2014,18:607 Page6of14
http://ccforum.com/content/18/6/607
Pr_1 ROC area: 0.7332
Pr_2 ROC area: 0.7692
Reference
0.00 0.25 0.50 0.75 1.00
1-Specificity
Figure1Receiveroperatorcharacteristic(ROC)curvesofmortality-associatedfactorsat1hourafterreturnofspontaneouscirculation
(ROSC)(areaunderthecurve(AUC)0.733,CI(0.681to0.785);P=0.001)andat24hoursafterROSC(AUC0.769,CI(0.720to0.819);
P=0.001).
López-Herceetal.CriticalCare2014,18:607 Page7of14
http://ccforum.com/content/18/6/607
Table4Comparisonbetweenpatientswithpediatriccerebralperformancecategory(PCPC)1to2andthose
withPCPC>2
PCPC1to2 PCPC>2 P-value
Mean(SD) Mean(SD)
Gasometry1h
pH 7.29(0.14) 7.24(0.17) 0.120
PaO,mmHg 118.0(104.9) 88.3(58.8) 0.330
2
PaO/FiO 175.1(143.1) 121.2(89.8) 0.111
2 2
PaCO,mmHg 46.1(14.5) 45.6(19.4) 0.297
2
COHmEq/L 21.8(6.9) 19.1(7.4) 0.025
3
Baseexcess -3.4(9.6) -7.1(9.4) 0.042
Lacticacid,mmol/L 5.8(11.3) 8.1(6.5) 0.003
FiO 77.9(27.8) 76.8(26.8) 0.867
2
Gasometry24h
pH 7.39(0.08) 7.39(0.12) 0.546
PaO,mmHg 96.7(66.0) 77.4(40.3) 0.094
2
PaO/FiO 207.1(132.7) 162.5(119.8) 0.053
2 2
PaCO,mmHg 42.7(10.7) 43.8(13.1) 0.681
2
COH,mEq/L 25.2(5.0) 26.2(6.7) 0.389
3
Baseexcess 0.6(5.2) 1.5(7.7) 0.710
Lacticacid,mmol/L 2.2(2.9) 6.8(20.7) 0.405
FiO 53.3(24.4) 57.9(26.4) 0.425
2
Lacticacidclearance,% 37.1(81.9) 72.6(19.2) 0.009
Mechanicalventilation,% 94.4 97.4 0.667
Vasoactivetreatment
PatientswithpressorsafterROSC,% 57.9 77.5 0.033
InotropicscoreafterROSC 45.3(78.4) 36.4(52.6) 0.693
Patientswithdopamine,% 34 43.2 0.349
Dopaminedose,mcg/kg/min 9.4(4.9) 10.7(5.9) 0.518
Patientswithdobutamine,% 19 40.9 0.007
Dobutaminedose,mcg/kg/min 13.7(8.1) 9.2(4.9) 0.070
Patientswithadrenaline,% 20 18.2 1.000
Adrenalinedose,mcg/kg/min 0.6(0.6) 0.4(0.1) 0.667
Patientswithnoradrenaline,% 12 13.6 0.789
Noradrenalinedose,mcg/kg/min 0.8(0.7) 1.3(0.9) 0.312
Patientswithmilrinone,% 20 11.4 0.241
Milrinonedose,mcg/kg/min 0.8(0.2) 0.8(0.3) 0.812
Lengthofstay
DaysinthePediatricICU 17.3(17.9) 22.3(24.6) 0.610
Daysinhospitalward 16.3(18.1) 21.0(26.0) 0.648
Significantvaluesmarkedinbold.ROSC,returnofspontaneouscirculation.
inotropic drugs before CA, administration of sodium bi- Discussion
carbonate, PaCO <30 mmHg 1 hour after ROSC, To our knowledge, this is the first multicenter multi-
2
PaCO >50 mmHg one hour after ROSC and FiO ≥ national study that analyzed the association of early
2 2
0.8024hours afterROSC. post-ROSC factors with outcome of in-hospital cardiac
López-Herceetal.CriticalCare2014,18:607 Page8of14
http://ccforum.com/content/18/6/607
Table5Univariateanalysisofbadneurologicevolution(pediatriccerebralperformancecategory(PCPC)>2)according
topost-returnofspontaneouscirculation(ROSC)factors
Patients,% PCPC>2,% Oddsratio 95%CI P-value
Patients
Mechanicalventilation
No 4.7 16.7 1.000
Yes 95.3 30.9 2.235 0.252to19.791 0.470
Vasoactivedrugs
No 42.1 18.4 1.000
Yes 57.9 36 1.739 0.793to3.186 0.167
Adrenaline
No 80.6 31 1.000
Yes 19.4 28.6 0.889 0.358to2.207 0.800
Noradrenaline
No 87.5 30.2 1.000
Yes 12.5 33.3 1.158 0.405to3.313 0.785
Dopamine
No 63.2 27.5 1.000
Yes 36.8 35.8 1.475 0.714to3.049 0.294
Dobutamine
No 74.3 24.3 1.000
Yes 25.7 48.6 2.951 1.351to6.448 0.007
Milrinone
No 82.6 32.8 1.000
Yes 17.4 20 0.513 0.179to1.469 0.213
Vasoactive-inotropicscore
<14 48.1 43.2 1.000
>14 51.9 35 0.707 0.282to1.772 0.459
EchocardiographicrhythmafterROSC
Sinusrhythm 74 27.8 1.000
Otherrhythms 26 36.8 1.497 0.685to3.274 0.312
Recoveryofspontaneousbreathing
Yes 65.3 25.5 1.000
No 34.7 33.3 1.340 0.648to2.767 0.430
pH1h
7.30to7.50 40.8 21.6 1.000
<7.30 54.4 32.4 1.739 0.752to4.023 0.196
>7.50 4.8 33.3 1.818 0.293to11.265 0.521
PaO 1h
2
60to200mmHg 45.2 33.3 1.000
<60mmHg 40.5 29.4 0.833 0.368to1.885 0.661
>200mmHg 14.3 16.7 0.400 0.103to1.553 0.186
PaCO 1h
2
30to50mmHg 62.1 23.4 1.000
<30mmHg 9.7 50 3.278 0.940to11.425 0.062
>50mmHg 28.2 37.1 1.937 0.815to4.601 0.134
López-Herceetal.CriticalCare2014,18:607 Page9of14
http://ccforum.com/content/18/6/607
Table5Univariateanalysisofbadneurologicevolution(pediatriccerebralperformancecategory(PCPC)>2)according
topost-returnofspontaneouscirculation(ROSC)factors(Continued)
CO H1h
3
20to26mEq/L 34.7 23.8 1.000
<20mEq/L 44.6 38.9 2.036 0.831to4.991 0.120
>26mEq/L 20.7 20 0.800 0.239to2.683 0.718
BE
+4to-4 24.8 25 1.000
<-4 61.1 33.3 1.500 0.557to4.041 0.423
>+4 14.2 18.8 0.692 0.152to3.163 0.635
FiO 1h
2
<0.50 50.9 25.5 1.000
0.50to0.79 25.9 32.1 1.125 0.324to3.909 0.853
≥0.80 23.1 44 1.125 0.409to3.097 0.820
PaO /FiO 1h
2 2
>300 15.9 16.7 1.000
200to300 12.4 14.3 3.049 0.083to11.149 0.092
<200 71.7 34.6 1.286 0.224to7.370 0.778
Lacticacid1h
<2mmol/L 21.3 6.2 1.000
2to5mmol/L 37.3 25 3.520 0.675to18.366 0.135
>5mmol/L 41.3 41.9 9.263 1.883to45.560 0.006
pH24h
7.30to7.50 80.6 26 1.000
<7.30 12.9 43.8 2.214 0.749to6.545 0.151
>7.50 6.5 62.5 4.744 1.059to21.248 0.042
PaO 24h
2
60to200mmHg 58.5 29.2 1.000
<60mmHg 36.6 37.8 1.474 0.670to3.243 0.334
>200mmHg 4.9 0 0
PaCO 24h
2
30to50mmHg 76.9 24.1 1.000
<30mmHg 5.6 50 3.150 0.589to16.859 0.180
>50mmHg 17.6 52.6 3.500 1.248to9.819 0.017
CO H24h
3
20to26mEq/L 43 26.9 1.000
<20mEq/L 15.7 26.3 0.969 0..295to3.189 0.959
>26mEq/L 41.3 36 1.527 0.658to3.544 0.325
BE24h
+4to-4 50 19.6 1.000
<-4 23.2 38.5 2.557 0.914to7.155 0.774
>+4 26.8 46.7 3.580 1.351to9.482 0.010
FiO 24h
2
<0.50 21.4 28 1.000
0.50to0.79 19.7 30.4 1.387 0.511to3.765 0.521
≥0.80 59 30.4 2.301 0.850to6.229 0.100
López-Herceetal.CriticalCare2014,18:607 Page10of14
http://ccforum.com/content/18/6/607
Table5Univariateanalysisofbadneurologicevolution(pediatriccerebralperformancecategory(PCPC)>2)according
topost-returnofspontaneouscirculation(ROSC)factors(Continued)
PaO /FiO 24h
2 2
>300 21 13.6 1.000
200to300 17.1 22.2 3.128 0.974to10.049 0.056
<200 61.9 40 1.312 0.284to6.067 0.728
Lacticacid24h
<2mmol/L 66.7 26.9 1.000
2to5mmol/L 20.5 31.2 1.234 0.364to4.187 0.736
>5mmol/L 12.8 40 1.810 0.444to7.380 0.408
Significantvaluesmarkedinbold.
arrest in children according to the Utstein style guide- although capnography values can be altered in patients
lines. Sustained ROSC was achieved in 69.5% patients withabnormalPaO /FiO .
2 2
but secondary in-hospital mortality among the initial PaO was not associated with mortality in the univariate
2
survivors of CA was 43.5% and survival to hospital dis- or in the multivariate analysis at 1 hour and at 24 hours
charge wastherefore39.2%. after ROSC. Two recent retrospective studies in children
didnotfindthisassociationbetweenmortalityandoxygen-
Oxygenationandventilationparameters ation either [20,24]. Nevertheless, another retrospective
Several studies, including our previous analysis, showed studythatanalyzed1,875pediatricpatientsfoundacorrel-
that alterations in ventilation and oxygenation during the ationbetweenmortalityinthePICUandhypoxiaand,toa
first hours after ROSC are associated with prognosis lesserextent,withhyperoxia.Thisstudydidnotanalyzethe
[14,20-24]. Our study shows that PaCO <30 mmHg and relationshipbetweenventilationandmortality[21].
2
>50mmHgat1hourandPaCO >50mmHgat24hours Inourstudy,non-survivorshadhigherFiO thansurvi-
2 2
afterROSCaremortalityindicators[14].Ourresultsdiffer vors, and the univariate analysis showed that FiO ≥0.80
2
from those reported in a retrospective study in 195 chil- wasassociatedwithmortality.Themultivariatelogisticre-
dren after CA, in which no relationship was found be- gressionstudyshowedthathighFiO couldbeconsidered
2
tween ventilation and mortality [20]. Hyperventilation a risk factor only at 24 hours after ROSC. Elevated FiO
2
may increase mortality and brain damage by reducing maycausecellulartoxicityasshowninpreviousstudiesin
cerebralbloodflowandtissueperfusionresultinginische- neonates[25].Ontheotherhand,elevatedFiO couldalso
2
mia[22].Ontheotherhand,hypoventilationmayincrease indicateagreaterneedforoxygen,asworsetissueoxygen-
the risk of cerebral edema and intracranial hypertension ation may exist. Nevertheless, no relationship was found
duetocerebralvasodilation[23].Inaddition,hypercapnia between PaO orPaO /FiO and mortality in the patients
2 2 2
can impair myocardial function and induce vasoconstric- in our study, and it may be that these patients did not
tion of the pulmonary vascular bed [23]. Our findings require such a high FiO . On the other hand we did not
2
highlight the importance of monitoring ventilation using find association between ventilation and oxygenation pa-
capnography and blood gas analysis in order to rapidly rameters and neurologic outcome. This may be because
achieve an appropriate ventilation status after ROSC, the number of patients with hypoxia and hyperoxia was
Table6Multivariatelogisticregressionstudyincludingpre-arrest,resuscitationandpost-returnofspontaneous
circulation(ROSC)mortalityriskfactors
Mortalityriskfactors Oddsratio 95%CI P-value
Hemato-oncologicillness 2.633 1.072to6.469 0.035
Neurologiccauseofcardiacarrest 5.528 1.726to17.701 0.004
Placeofarrest(emergencydepartment) 3.170 1.707to5.887 <0.001
Inotropicdrugspriortocardiacarrest 2.191 1.194to4.020 0.011
Sodiumbicarbonateadministrationduringresuscitation 3.241 1.850to5.677 <0.001
PaCO <30mmHg1hafterROSC 2.623 1.076to6.397 0.034
2
PaCO >50mmHg1hafterROSC 2.004 1.011to3.970 0.046
2
FiO ≥0.8024hoursafterROSC 4.611 1.934to10.993 <0.001
2
López-Herceetal.CriticalCare2014,18:607 Page11of14
http://ccforum.com/content/18/6/607
insufficient to detect significant differences, or that only analyzed in order to assess hemodynamic alterations.
important alterations in oxygenation could influence Otherhemodynamicparameters,suchasheartrate,blood
neurologicoutcome. pressure or central venous pressure were not registered.
We think that it is possible that ventilation and oxygen- The non-surviving group had a greater percentage of
ation could influence the prognosis of children who suffer patients requiring vasoactive support and at higher
CA. However, multicenter controlled studies with a suffi- doses (higher inotropic index) than the surviving group.
cient number of patients are needed because many other The univariate and multivariate studies showed that
factors besides ventilation and oxygenation may influence vasoactive-inotropic score >14 was significantly associ-
outcomeinCApatients. ated with mortality.
Several studies have found that the need for pressors
Lactidacid previous to CA is a mortality risk factor, both in adults
Lactic acid is one of the most commonly used parame- [34-37] and in children [4,6,8,11]. Our study shows that
ters to assess and monitor hypoperfusion or tissue hyp- the need for pressors and at higher doses (vasoactive-
oxia in critically ill patients, as it has been demonstrated inotropic score) after CA is associated with higher risk
to have good prognostic capacity and it is easy and fast of mortality. This fact has also been found by Meert
to measure [26]. Lactate levels in patients who have re- et al. [9]. This highlights the influence of early
covered from CA probably reflect the severity of the hemodynamic alterations on outcome in children after
ischemia-reperfusion syndrome. Nevertheless, high lactic CA, and the importance of treating these alterations
acid levels may exist without the presence of tissue hy- as they appear.
poperfusion due to the administration of adrenaline or On the other hand, a large percentage of patients re-
to the presence of hyperglycemia, which are very com- ceived more than one vasoactive agent after ROSC. That
monafterCA[26]. may be the cause for not finding a significant association
Several studies have found that lactate levels in the between mortality and the administration or dosage of
first 48 hours after CA is lower in survivors and in pa- any specific vasoactive drug, but with the intensity of
tients without neurological damage [27-29]. The levels vasoactive treatment in general. Inotropic score has
of lactate after ROSC and 12 or 24 h later were signifi- proved to be appropriate in assessing vasoactive support
cantly higher in non survivors adults and children after and its relationship with mortality in several studies in
out-of-hospital and in-hospital CA [9,30-33]. Lactate children in shock, after open heart surgery and after
clearance within the first 24 hours (lactate after ROSC heart transplantation [18,38,39]. Rhodes et al. found that
minus lactate 24 hours after ROSC)×100/lactate after the inotropic score was higher in non-survivors than in
ROSC) is significantly higher in survivors than in non- survivors with CA after congenital heart surgery [39].
survivors[30-32]. Our study also suggests that the vasoactive-inotropic
In our study, non-survivors had more acidosis both at score may be a useful prognostic indicator in children
1 hour and at 24 hours after ROSC. Acidosis was mainly afterCA.
due to metabolic acidosis, with lower bicarbonate levels A recent retrospective study in adults showed that the
and higher base deficit in non-survivors than in survi- combination of elevated lactate levels and the need for
vors. Nevertheless, the only factor associated with mor- vasoactive support had a good mortality predictive cap-
tality in the logistic regression analysis was lactic acid at acity in patients that recovered from CA [40]. Our
1 hour and at 24 hours after ROSC. Non-survivors pre- results agree with those from the mentioned study,
sented significantly higher levels of lactic acid at 1 and although in our study the dose of vasoactive support
24 hours after ROSC, and lactic acid levels >5 mmol/L also proved to have mortality predictive capacity. Fur-
were associated with higher mortality in the univariate thermore, PaCO levels, which were not registered in
2
andmultivariateanalysis. the study in adults, also proved to have prognostic
Although lactate at 1 and at 24 hours after ROSC was capacity in our study. On the other hand, lactic acid
higher in non-survivors, no significant differences were levels >5 mmol/L at 1 hour after ROSC was the only
foundinlactate clearance,becauselactateacidlevelssig- factor that was associated with bad neurological out-
nificantly decreased in the first 24 hours in both groups come in our study.
(from 16.9 to 5.8 mmol/L in non-survivors and from 6.7
to3.7mmol/L insurvivors). Pre-arrest,resuscitationandpost-ROSCmultivariate
analysis
Vasoactivetreatment Meertetal.[9]performedamultivariateanalysisincluding
Hemodynamic alterations after ROSC are also late pre-arrest,resuscitationand12hpost-ROSCfactors.Inthis
mortality risk factors. Cardiac rhythm after ROSC and studytheonlypost-ROSCfactorassociatedwithsurvivalal
need for vasoactive drugs in the first 24 hours were hospital discharge was the responsive pupils after ROSC.
López-Herceetal.CriticalCare2014,18:607 Page12of14
http://ccforum.com/content/18/6/607
Conversely, our multivariate analysis, including pre- (cid:1) Themost importantearlymortalityriskfactors after
arrest, resuscitation and post-ROSC factors, showed ROSCin-hospital CAinchildren werehyperventila-
that the post-ROSC factors associated with mortality tion,hypoventilation, needforhighdosesofino-
were hypoventilation and hyperventilation 1 hour after tropic drugs,highlactic acidlevelsand highFiO
2
ROSC and high FiO 24 hours after ROSC, highlighting requirements
2
theimportanceofthecontrolof ventilationandoxygen- (cid:1) Highlacticacidlevelsat1hourafterROSCwere
ationafterROSC. associatedwith badneurologicaloutcome
(cid:1) Early treatment of hemodynamic and respiratory
Limitations disturbances afterROSC couldimprovemortalityin
Our study has several limitations. One of them is that initialsurvivorsofCA
hemodynamic variables such as heart rate, blood pressure
andcentralvenouspressureinthefirst24hoursafterROSC Additional file
were not registered, making it impossible to accurately as-
sess the presence of shock in these patients. In a recent Additionalfile1:ListofHospitalReviewBoards.
studyhypotensionafterROSCwasrelatedtobadprognosis
[41]. Hypothermia or hyperthermia and the parameters of Abbreviations
mechanicalventilationwerenotregisteredneither. BE:baseexcess;bpm:beatsperminute;CA:cardiacarrest;
CPR:cardiopulmonaryresuscitation;ECG:electrocardiographic;
Pre-arrestvaluesoflactateor vasoactive-inotropicscore
ECMO:extracorporealmembraneoxygenation;FiO:inspiredoxygenfraction;
2
could influence post-ROSC values but we did not register OR:adjustedoddsratios;PaO:arterialpartialpressureofoxygen;
2
pre-arrest lactate and VIS data in our patients. On the PCPC:pediatriccerebralperformancecategory;PICU:PediatricIntensiveCare
Unit;ROC:receiveroperatorcharacteristic;ROSC:returnofspontaneous
otherhand,ourstudyhasonlyanalyzedprognosticfactors
circulation;VIS:vasoactive-inotropicindex.
in the first 24 hours after ROSC, which may be the most
important but not the only ones. Other factors that affect Competinginterests
prognosis but may appear in the following days, such as Allauthorsdeclarethattheyhavenocompetinginterests.
nosocomial infections or multiple organ failure, were not
Authors’contributions
analyzed. Actually, the median PICU stay for non- JLH:conceived,designedandcoordinatedthestudy,analyzeddataand
survivorswas8 days, and manyofthese patients died be- draftedthemanuscript.JC:participatedinthedesignandcoordinationof
thestudy,inthestatisticalanalysisofdataandhelpedtodraftthe
causeofcomplicationsduetomulti-organfailure.
manuscript.MM:participatedinthecoordinationofthestudy,analysisof
Finally, only 61% of patients have neurologic outcome dataandhelpedtodraftthemanuscript.SC:participatedinthecoordination
evaluation, although there were no differences in base- ofthestudy,analysisofdataandhelpedtodraftthemanuscript.ARC:
participatedinthecoordinationofthestudy,analysisofdataandhelpedto
line characteristics between patients with and without a
draftthemanuscript.CC:participatedinthecoordinationofthestudy,
neurologic outcome measure. On the other hand, only a analysisofdataandhelpedtodraftthemanuscript.ARN:participatedinthe
small number of patients had bad neurological out- designandcoordinationofthestudyandhelpedtodraftthemanuscript.
AC:participatedinthedesignandcoordinationofthestudyandhelpedto
comes. This is why the power of the statistical analysis
draftthemanuscript.Allauthorsreadandapprovedthefinalmanuscript.
in relationship with neurological outcome is poor, so re-
sults must be interpreted with caution. Therefore, more Acknowledgements
studies are needed to prospectively assess both early and ThisstudywassupportedinpartbygrantRT02377fromtheScienceand
TechnologyforDevelopment(CYTED)ProgramandbygrantPI081167from
late post-ROSC mortality and neurologic outcome risk
CarlosIIIInstituteofHealth,Spain.Theydidnotparticipateindesign,
factorsinchildren after CA. collection,analysis,interpretationofdata,writingofthemanuscriptorthe
decisiontosubmitthemanuscriptforpublication.Listoftheinvestigatorsof
theIberoamericanPediatricCardiacArrestStudyNetwork:JesúsLópez-Herce,
Conclusions
JimenadelCastillo,JavierUrbano,AngelCarrillo,JoseMariaBellon,Sarah
We conclude that secondary in-hospital mortality among Fernández(HospitalGeneralUniversitarioGregorioMaranon,Madrid,Spain),
the initial survivors of CA is high (43.5% in our study). MarthaMatamoros,RogerRodríguez,AllisonCallejas,DouglasCarranza,Hilda
Zerón(HospitalEscuela,Tegucigalpa,Honduras),SoniaCanadas,Pedro
The most important early mortality risk factors after
Dominguez(HospitalValledeHebron,Barcelona,Spain),AnaRodriguez
ROSC in in-hospital CA in children are hyperventilation, Calvo,LorenzoMarcos(HospitalNinoJesus,Tucuman,Argentina),Corrado
hypoventilation, high FiO requirements need for high Cechetti(OspedaleBambinuGesu,Roma,Italy),MartaSilva(HospitalSan
2
Joao,Porto,Portugal),ReginaGrigolliCesar(IrmandadedaSantaCasade
doses of inotropic drugs and high lactic acid levels. High
Misericordia,SaoPaulo,Brasil),JavierPilarOrive(HospitaldeCruces,
lactic acid levels at 1 hour after ROSC were associated Baracaldo,Spain),AnaMariaNieva(HospitaldeNinosRicardoGutierrez,
withbadneurologicaloutcome. BuenosAires,Argentina),AntonioRodriguez-Nunez(HospitalClinico
Universitario,SantiagodeCompostela,Spain),MartaParada(Hospital
Pediatrico,Coimbra,Portugal),MariaAngelesGarciaTeresa(HospitalNino
Key messages Jesus,Madrid,Spain),DiPrietroPasquale(OspedaleGaslini,Genova,Italy),
MiguelAngelDelgado(HospitalUniversitarioLaPaz,Madrid,Spain),Mauricio
(cid:1) Secondaryin-hospitalmortalityamongthe initial Fernandez,HospitalPabloTobonUribe,Medellin,Colombia),RoxanaFlavia
Jaen(HospitalBritanico,BuenosAires,Argentina),JuanGarbayoSolana
survivorsofCAishigh(43.5% inourstudy) (HospitalReinaSofia,Cordoba,Spain),RaulBorregoDominguez(Hospital
López-Herceetal.CriticalCare2014,18:607 Page13of14
http://ccforum.com/content/18/6/607
VirgendelaSalud,Toledo,Spain),VictorMonreal(HospitalRobertodelRio, 8. WuET,LiMJ,HuangSC,WangCC,LiuYP,LuFL,KoWJ,WangMJ,WangJK,
SantiagodeChile,Chile),CristinaMolinos(HospitaldeCabueñes,Asturias, WuMH:SurveyofoutcomeofCPRinpediatricin-hospitalcardiacarrest
Spain),IolsterThomas(HospitalUniversitarioAustral,BuenosAires,Argentina), inamedicalcenterinTaiwan.Resuscitation2009,80:443–448.
RicardoIramain(HospitalNacionaldeAsunción,Asuncion,Paraguay),Juan 9. MeertKL,DonaldsonA,NadkarniV,TievesKS,SchleienCL,BrilliRJ,ClarkRS,
CarlosdeCarlos(HospitalSonDureta,PalmadeMallorca,Spain),CorsinoRey ShaffnerDH,LevyF,StatlerK,DaltonHJ,vanderJagtEW,HackbarthR,Pretzlaff
Galán(HospitalCentraldeAsturias,Oviedo,Spain),CustodioCalvoMacías, R,HernanL,DeanJM,MolerFW,PediatricEmergencyCareAppliedResearch
HospitalCarlosHaya,Málaga,Spain),OliviaPérezQuevedo(HospitalMaterno Network:Multicentercohortstudyofin-hospitalpediatriccardiacarrest.
InfantildeLasPalmas,LasPalmasdeGranCanaria,Spain),AdrianaKoliski PediatrCritCareMed2009,10:544–553.
(HospitaldaClinicasdaUFPR,Curitiba,Brasil),SantiagoCampos(Hospital 10. BerensRJ,CassidyLD,MatcheyJ,CampbellD,ColpaertKD,WelchT,
SOLCA,Quito,Ecuador),AlfredoReparaz(ComplexoHospitalarioUniversitario LawsonM,PetersonC,O'FlynnJ,DearthM,TievesKS:Probabilityof
deVigo,Vigo,Spain),SiviaSanchezPerez(CorporacionParcTaul,Sabadell, survivalbasedonetiologyofcardiopulmonaryarrestinpediatric
Spain),DeolindaMatos(HospitalGarciadeOrta,Almada,Portugal),Claudia patients.PaediatrAnaesth2011,21:834–840.
CarolinaBenaroyaHospitalRegionalRioGallegos,RioGallegos,Argentina), 11. López-HerceJ,DelCastilloJ,MatamorosM,CañadasS,Rodriguez-CalvoA,
JessicaOrtizRodríguez(HospitalSanJuandeDios,Barcelona,Spain),Pedro CecchettiC,Rodriguez-NúñezA,AlvarezAC,IberoamericanPediatricCardiac
PabloOyagüez(ComplejoAsistencialdeBurgos,Spain),JuanCarlosdeCarlos ArrestStudyNetworkRIBEPCI:Factorsassociatedwithmortalityin
(HospitalSonDureta,PalmadeMallorca,Spain),MarioJoséSánchez pediatricin-hospitalcardiacarrest:aprospectivemulticentermulti-
Fernández(HospitalJosepTrueta,Gerona,Spain),CristinaMolinos(Hospital nationalobservationalstudy.IntensiveCareMed2013,39:309–318.
deCabueñes,Asturias,Spain),ConcepciónGoñiOrayen(HospitalVirgendel 12. MolerFW,MeertK,DonaldsonAE,NadkarniV,BrilliRJ,DaltonHJ,ClarkRS,
Camino,Pamplona,Spain),AsunciónPinoVázquez(HospitalClínicode ShaffnerDH,SchleienCL,StatlerK,TievesKS,HackbarthR,PretzlaffR,vanderJagt
Valladolid,Spain),MªElenaMayLlanas(HospitalMutuadeTarrasa,Barcelona, EW,LevyF,HernanL,SilversteinFS,DeanJM,PediatricEmergencyCareApplied
Spain),AbiánMontesdeocaMelián(HospitalUniversitariodeCanarias, ResearchNetwork:In-hospitalversusout-of-hospitalpediatriccardiacarrest:a
Tenerife,Spain),IsabelLucíaBenítezGómez(HospitalVirgendelRocío, multicentercohortstudy.CritCareMed2009,37:2259–2267.
Sevilla,Spain),AntoniodeFrancisco(HospitalGermansTriasiPujol, 13. DonoghueAJ,NadkarniVM,ElliottM,DurbinD,AmericanHeartAssociation
Barcelona,Spain).SantiagoHermógenesEsquivel(HospitalOscarAlende, NationalRegistryofCardiopulmonaryResuscitationInvestigators:Effectof
LomasdeZamora;VicenteLópezyPlanes,GeneralRodriguez,Argentina), hospitalcharacteristicsonoutcomesfrompediatriccardiopulmonary
CeciliaAndreaChede(HospitaldeClínicasUBA,Caba,Argentina),Gabriel resuscitation:areportfromthenationalregistryofcardiopulmonary
CassalettiBustillo(ClínicaShaio,Bogota,Colombia),LourdesMarroquinYanez resuscitation.Pediatrics2006,118:995–1001.
(HospitalInfantildeMéxicoFedericoGómez,Mexico,Spain). 14. DelCastilloJ,López-HerceJ,MatamorosM,CañadasS,Rodriguez-CalvoA,
CechettiC,Rodriguez-NúñezA,AlvarezAC,IberoamericanPediatricCardiac
Authordetails ArrestStudyNetworkRIBEPCI:Hyperoxia,hypocapniaandhypercapniaas
1PediatricIntensiveCareDepartment,HospitalGeneralUniversitarioGregorio outcomefactorsaftercardiacarrestinchildren.Resuscitation2012,
Maranón,DrCastelo47,28009Madrid,Spain.2InstitutodeInvestigación 83:1456–1461.
SanitariadelHospitalGregorioMarañóndeMadrid,ReddeSaludMaterno 15. Iberoamericanstudyofcardiacarrestinchildren.[www.pcrpediatrica.es]
InfantilydelDesarrollo(RedSAMID),DrCastelo47,28009Madrid,Spain. 16. CumminsR,ChamberlainD,HazinskiMF,NadkarniV,KloekW,KramerE:
3HospitalEscuela,BoulevardSuyapa,Tegucigalpa,Honduras.4HospitalValle
Recommendedguidelinesforreviewing,reporting,andconducting
deHebrón,PasseigValld’Hebron,119-12908035Barcelona,Spain.5Hospital researchoninhospitalresuscitation:thein-hospital“Utsteinstyle”.
NinoJesús,Hungría750,4000SanMigueldeTucumán,Argentina.6Ospedale Resuscitation1997,34:151–183.
BambinuGesu,ViadellaTorrediPalidoro,00050FiumicinoRoma,Italy. 17. JacobsI,NadkarniV,BahrJ,BergRA,BilliJE,BossaertL,CassanP,Coovadia
7HospitalClínicoUniversitariodeSantiagodeCompostela,Travesíade
A,D'EsteK,FinnJ,HalperinH,HandleyA,HerlitzJ,HickeyR,IdrisA,Kloeck
Choupana,s/n,15706ACoruña,Spain.8IberoamericanPediatricCardiac
W,LarkinGL,ManciniME,MasonP,MearsG,MonsieursK,MontgomeryW,
ArrestStudyNetworkRIBEPCI,DrCastelo47,28009Madrid,Spain. MorleyP,NicholG,NolanJ,OkadaK,PerlmanJ,ShusterM,SteenPA,Sterz
F,etal:Cardiacarrestandcardiopulmonaryresuscitationoutcomes
Received:30May2014Accepted:20October2014 reports:updateandsimplificationoftheutsteintemplatesfor
resuscitationregistries:astatementforhealthcareprofessionalsfroma
taskforceoftheinternationalliaisoncommitteeonresuscitation
(Americanheartassociation,Europeanresuscitationcouncil,Australian
References
resuscitationcouncil,NewZealandresuscitationcouncil,heartand
1. SuominenP,OlkkolaKT,VoipioV,KorpelaR,PaloR,RasananJ:Utsteinstyle
strokefoundationofCanada,InterAmericanheartfoundation,
reportingof-inhospitalpaediatriccardiopulmonaryresuscitation.
Resuscitation2000,45:17–25.
resuscitationcouncilsofsouthernAfrica.Circulation2004,110:3385–3397.
18. GaiesMG,GurneyJG,YenAH,NapoliML,GajarskiRJ,OhyeRG,CharpieJR,Hirsch
2. ReisAG,NadkarniV,PerondiMB,GrisiS,BergRA:Aprospective
JC:Vasoactive-inotropicscoreasapredictorofmorbidityandmortalityin
investigationintotheepidemiologyofin-hospitalpediatric
infantsaftercardiopulmonarybypass.PediatrCritCareMed2010,11:234–238.
cardiopulmonaryresuscitationusingtheInternationalUtsteinreporting
style.Pediatrics2002,109:200–209. 19. FiserDH,LongN,RobersonPK,HeffleyG,ZoltenK,Brodie-FowlerM:Rela-
3. López-HerceJ,GarciaC,DominguezP,CarrilloA,Rodriguez-NunezA,Calvo tionshipofpediatricoverallperformancecategoryandpediatriccerebral
C,DelgadoMA,andtheSpanishStudyGroupofCardiopulmonaryArrestin performancecategoryscoresatpediatricintensivecareunitdischarge
Children:Characteristicsandoutcomeofcardiorespiratoryarrestin withoutcomemeasurescollectedathospitaldischargeand1-and6-
children.Resuscitation2004,63:311–313. monthfollow-upassessments.CritCareMed2000,28:2616–2620.
4. Rodriguez-NunezA,Lopez-HerceJ,GarciaC,CarrilloA,DominguezP,Calvo 20. BennettKS,ClarkAE,MeertKL,TopjianAA,SchleienCL,ShaffnerDH,DeanJM,
C,DelgadoMA,andtheSpanishStudyGroupofCardiopulmonaryArrestin MolerFW,PediatricEmergencyCareMedicineAppliedResearchNetwork:
Children:Effectivenessandlong-termoutcomeofcardiopulmonary Earlyoxygenationandventilationmeasurementsafterpediatriccardiac
resuscitationinpaediatricintensivecareunitsinSpain.
arrest:lackofassociationwithoutcome.CritCareMed2013,41:1534–1542.
Resuscitation2006,71:301–309. 21. FergusonLP,DurwardA,TibbySM:Relationshipbetweenarterialpartial
5. TibballsJ,KinneyS:Aprospectivestudyofoutcomeofin-patient oxygenpressureafterresuscitationfromcardiacarrestandmortalityin
paediatriccardiopulmonaryarrest.Resuscitation2006,71:310–318. children.Circulation2012,126:335–342.
6. DeMosN,vanLitsenburgRR,McCrindleB,BohnDJ,ParshuramCS: 22. CurleyG,KavanaghBP,LaffeyJG:Hypocapniaandtheinjuredbrain:more
Pediatricin-intensive-care-unitcardiacarrest:incidence,survival,and
harmthanbenefit.CritCareMed2010,38:1348–1359.
predictivefactors.CritCareMed2006,34:1209–1215. 23. CurleyG,LaffeyJG,KavanaghBP:Bench-to-bedsidereview:carbon
7. MeaneyPA,NadkarniVM,CookEF,TestaM,HelfaerM,KayeW,LarkinGL,
dioxide.CritCare2010,14:220.
BergRA,NationalRegistryofCardiopulmonaryResuscitationInvestigators: 24. Guerra-WallaceMM,CaseyFL3rd,BellMJ,FinkEL,HickeyRW:Hyperoxia
Highersurvivalratesamongyoungerpatientsafterpediatricintensive andhypoxiainchildrenresuscitatedfromcardiacarrest.PediatrCritCare
careunitcardiacarrest.Pediatrics2006,118:2424–2433. Med2013,14:e143–e148.
López-Herceetal.CriticalCare2014,18:607 Page14of14
http://ccforum.com/content/18/6/607
25. SaugstadOD:Resuscitationofnewborninfants:fromoxygentoroomair.
Lancet2010,376:1970–1971.
26. JansenTC,vanBommelJ,BakkerJ:Bloodlactatemonitoringincriticallyill
patients:asystematichealthtechnologyassessment.CritCareMed2009,
37:2827–2839.
27. KliegelA,LosertH,SterzF,HolzerM,ZeinerA,HavelC,LaggnerAN:Serial
lactatedeterminationsforpredictionofoutcomeaftercardiacarrest.
Medicine(Baltimore)2004,83:274–279.
28. MüllnerM,SterzF,DomanovitsH,BehringerW,BinderM,LaggnerAN:The
associationbetweenbloodlactateconcentrationonadmission,durationof
cardiacarrest,andfunctionalneurologicalrecoveryinpatientsresuscitated
fromventricularfibrillation.IntensiveCareMed1997,23:1138–1143.
29. ShinozakiK,OdaS,SadahiroT,NakamuraM,HirayamaY,WatanabeE,Tateishi
Y,NakanishiK,KitamuraN,SatoY,HirasawaH:Bloodammoniaandlactate
levelsonhospitalarrivalasapredictivebiomarkerinpatientswithout-of-
hospitalcardiacarrest.Resuscitation2011,82:404–409.
30. KaragiannisC,GeorgiouM,KouskouniE,IacovidouN,SantosT:Association
oflactatelevelswithoutcomeafterin-hospitalcardiacarrest.
Resuscitation2012,83:e175–e176.
31. GrossestreuerA,PermanS,NapoliA,AbellaB,BeckerL,LearyM,GaieskiD:
Associationbetweenserumlactatelevels,lactateclearanceandsurvival
todischargeinpost-cardiacarrestpatients.Resuscitation2012,83:e2.
32. StarodoubR,AbellaB,GrossstreuerA,ShoferFS,PermanSM,LearyM,Gaiesiki
DF:Associationofserumlactatelevelsandsurvivaloutcomesinpatients
undergoingtherapeutichypothermiaaftercardiacarrest.Resuscitation2012,
83:e2.
33. TopjianAA,ClarkAE,CasperTC,BergerJT,SchleienCL,DeanJM,MolerFW,
PediatricEmergencyCareAppliedResearchNetwork:Earlylactateelevations
followingresuscitationfrompediatriccardiacarrestareassociatedwith
increasedmortality.PediatrCritCareMed2013,14:e380–e387.
34. TianJ,KaufmanDA,ZarichS,ChanPS,OngP,Amoateng-AdjepongY,Manthous
CA,AmericanHeartAssociationNationalRegistryforCardiopulmonary
ResuscitationInvestigators:Outcomesofcriticallyillpatientswhoreceived
cardiopulmonaryresuscitation.AmJRespirCritCareMed2010,182:501–506.
35. GrigoriyanA,VazquezR,PalvinskayaT,BindelglassG,RishiA,Amoateng-Adjepong
Y,ManthousCA:Outcomesofcardiopulmonaryresuscitationforpatientson
vasopressorsorinotropes:Apilotstudy.JCritCare2009,24:415–418.
36. LevyPD,YeH,ComptonS,ChanPS,LarkinGL,WelchRD:Factorsassociated
withneurologicallyintactsurvivalforpatientswithacuteheartfailureand
in-hospitalcardiacarrest.CircHeartFail2009,2:572–581.
37. LarkinGL,CopesWS,NathansonBH,KayeW:Pre-resuscitationfactors
associatedwithmortalityin49,130casesofin-hospitalcardiacarrest:a
reportfromthenationalregistryforcardiopulmonaryresuscitation.
Resuscitation2010,81:302–311.
38. DavidsonJ,TongS,HancockH,HauckA,daCruzE,KauffmanJ:
Prospectivevalidationofthevasoactive-inotropicscoreandcorrelation
toshort-termoutcomesinneonatesandinfantsaftercardiothoracic
surgery.IntensiveCareMed2012,38:1184–1190.
39. RhodesJF,BlaufoxAD,SeidenHS,AsnesJD,GrossRP,RhodesJP,GrieppRB,
RossiAF:Cardiacarrestininfantsaftercongenitalheartsurgery.
Circulation1999,100:II194–II199.
40. CocchiMN,MillerJ,HunzikerS,CarneyE,SalciccioliJ,FarrisS,JoyceN,
ZimetbaumP,HowellMD,DonninoMW:Theassociationoflactateand
vasopresssorneedformortalitypredictioninsurvivorsofcardiacarrest.
MinervaAnestesiol2011,77:1063–1071.
41. TopjianAA,FrenchB,SuttonRM,ConlonT,NadkarniVM,MolerFW,Dean
JM,BergRA:Earlypostresuscitationhypotensionisassociatedwith Submit your next manuscript to BioMed Central
increasedmortalityfollowingpediatriccardiacarrest.CritCareMed2014, and take full advantage of:
42:1518–1523.
• Convenient online submission
doi:10.1186/s13054-014-0607-9
Citethisarticleas:López-Herceetal.:Postreturnofspontaneous • Thorough peer review
circulationfactorsassociatedwithmortalityinpediatricin-hospital • No space constraints or color figure charges
cardiacarrest:aprospectivemulticentermultinationalobservational
study.CriticalCare201418:607. • Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit
